US Patent Issued to THE CLEVELAND CLINIC FOUNDATION on Dec. 16 for "Assessment of atrial myocardial viability using spectral analysis of ultrasound" (Ohio, Minnesota Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,125, issued on Dec. 16, was assigned to THE CLEVELAND CLINIC FOUNDATION (Cleveland).

"Assessment of atrial myocardial viability using spectral analysis of ultrasound" was invented by Russell Fedewa (Shaker Heights, Ohio), Oussama Wazni (Bentleyville, Ohio) and Scott Anjewierden (Rochester, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Spectral parameters of ultrasound backscatter of myocardial tissue can be utilized to identify fibrosis and accurately assess myocardial viability during ablation procedures to treat atrial fibrillation. For example, a portion of myocardial tissue may be ultrasonically insonified, the backscatter signal of ultra...